🇺🇸 rituximab 1000 in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bacterial Test Positive — 1 report (10%)
  2. C-Reactive Protein Increased — 1 report (10%)
  3. Chills — 1 report (10%)
  4. Condition Aggravated — 1 report (10%)
  5. Drug Ineffective — 1 report (10%)
  6. Dyspnoea — 1 report (10%)
  7. Escherichia Infection — 1 report (10%)
  8. Hepatitis B — 1 report (10%)
  9. Hypophagia — 1 report (10%)
  10. Infection — 1 report (10%)

Source database →

rituximab 1000 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is rituximab 1000 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for rituximab 1000 in United States?

University Hospital, Toulouse is the originator. The local marketing authorisation holder may differ — check the official source linked above.